19 May 2013
Keywords: merck, co, pulls, out, bph, collaboration, synaptic
Article | 16 September 1999
Merck & Co has told Synaptic Pharmaceutical Corp that it isdiscontinuing clinical trials of the latter's alpha 1-a receptor blocker
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 September 1999
17 May 2013
© 2013 thepharmaletter.com